Stocks · Health care · Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA Clue Score36
United States Fiscal year ends December CIK 0001831828 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Patrick G Enright
Director
—
—
—
3,602,475
$133.29M
+7.6%
Marshall Fordyce
President and CEO
—
—
—
235,244
$8.70M
+37.7%
Sean Grant
Chief Financial Officer
—
—
—
114,181
$4.22M
+69.8%
Joseph R Young
SVP, Finance, Chief Acct Offcr
—
—
—
80,754
$2.99M
+52.0%
Laurence Matthew Skelton
Chief Commercial Officer
—
—
—
64,218
$2.38M
+40.2%
Robert Brenner
Chief Medical Officer
—
—
—
50,947
$1.89M
+4,153%
Jason S Carter
Chief Legal Officer
—
—
—
49,136
$1.82M
—
David Lee Johnson
Chief Operating Officer
—
—
—
45,727
$1.69M
+3,152%
William D. Turner
Chief Regulatory Officer
—
—
—
45,313
$1.68M
—
Nancy Lee Boman
Chief Regulatory Officer
—
—
—
44,987
$1.66M
—
Jane Wright-Mitchell
Chief Legal Officer
—
—
—
42,403
$1.57M
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.